Search
for
Sort by
Research 421–450 of 1000+
- Therapies
- Decision letter: Epithelial cells supply Sonic Hedgehog to the perinatal dentate gyrus via transport by platelets
- Autologous stromal vascular fraction cells combined with platelet-rich plasma for androgenic alopecia treatment: a case series
- An overview on 5α-reductase inhibitors
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Androgenetic alopecia; drug safety and therapeutic strategies
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- New Treatments for Hair Loss
- Ottawa, Ontario, Canada, February 13–16, 2013
- Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
- The Effect of Stromal Vascular Fraction for Patients with Androgenetic Alopecia
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- The Opportunities and Challenges regarding Induced Platelets from Human Pluripotent Stem Cells
- Cutaneous drug reactions
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- 15-Hydroxyprostaglandin Dehydrogenase Inhibitor Restores Endothelial Function Under Dihydrotestosterone-Induced Stress in Human Dermal Microvascular Endothelial Cells
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells
- General Dermatology
- Cytostatics and immunosuppressive drugs
- Clascoterone as a novel treatment for androgenetic alopecia